It exhibits potent immunomodulatory activity by downregulating pro-inflammatory cytokines such as TNF- and IL-6, while preserving epithelial integrity
Transformative care is made possible through Dr
BPC-157, or Body Protection Compound 157, is a synthetic peptide chain composed of 15 amino acids
We asked Stuart Phillips, professor in the McMaster Department of Kinesiology, about the rise of unapproved peptides and the risks, evidence, challenges, and proven alternatives
Characteristics of First-in-Human Clinical Trials Important aspects of FIH trials include the selection of a starting dose, a dose acceleration schedule, the study duration, and the administration route of the study drug
: , HPR,